Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00574) | |||||
---|---|---|---|---|---|
Name |
Quazepam
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
quazepam; Prosedar; Quazium; Dormalin; Oniria; Selepam; 36735-22-5; Sch 16134; Quazepamum [INN-Latin]; Sch-16134; UNII-JF8V0828ZI; 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione; 7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione; CHEBI:8694; JF8V0828ZI; Quazepamum; Quazapam; NSC-309702; 2H-1,4-Benzodiazepine-2-thione, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-; Cetrane; Doral [Sedative]; 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepine-2-thione; Doral (TN); EINECS 253-179-4; NSC 309702; Quazepam (JAN/USP/INN); Sch-161; BRN 0901084; Quazepam civ; DEA No. 2881; Quazepam [USAN:USP:INN:BAN]; Quazepam civ(200 mg); SCHEMBL29504; 5-24-04-00356 (Beilstein Handbook Reference); GTPL7288; CHEMBL1200472; DTXSID60190193; ZINC538266; NSC309702; DB01589; C07336; D00457; 735Q225; Q3927403; 2H-1, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-; 7-Chloro-5-(o-fluorophenyl)-1,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Insomnia | ICD-11: 7A00 | [1] | ||
PubChem CID | |||||
Formula |
C17H11ClF4N2S
|
||||
Canonical SMILES |
C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
|
||||
InChI |
1S/C17H11ClF4N2S/c18-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)19)23-8-15(25)24(14)9-17(20,21)22/h1-7H,8-9H2
|
||||
InChIKey |
IKMPWMZBZSAONZ-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=4999"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 386.8 | Topological Polar Surface Area | 47.7 | |
XlogP | 4 | Complexity | 539 | ||
Heavy Atom Count | 25 | Rotatable Bond Count | 2 | ||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 6 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Quazepam 15 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Sodium lauryl sulfate; Fd&c yellow no. 6; Magnesium stearate; Silicon dioxide; Powdered cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack; Galt Pharmaceuticals; Thompson Medical Solutions; Unit Dose Services | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.